Contrariwise, the second-generation mTOR inhibitor, PP242, that interacts with the ATP binding site of mTOR, effectively blocks the activation of both mTORC1 and mTORC2, regardless of the PTEN status, in the GBM cell lines analyzed. Here, MTOR is linked to glioblastoma.